Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A precise microdissection strategy enabled spatial heterogeneity analysis on the targeted region of formalin-fixed paraffin-embedded tissues. | Talanta | 2024 | 38963978 | PubTator, text mining | PubMed |
| Intermittent hypoxia exacerbates metabolic dysfunction-associated fatty liver disease by aggravating hepatic copper deficiency-induced ferroptosis. | FASEB J | 2024 | 38963329 | PubTator, text mining | PubMed |
| Kidney tea [Orthosiphon aristatus (Blume) Miq.] improves diabetic nephropathy via regulating gut microbiota and ferroptosis. | Front Pharmacol | 2024 | 38962302 | PubTator, text mining | PubMed |
| Neuronal ferroptosis and ferroptosis-mediated endoplasmic reticulum stress: Implications in cognitive dysfunction induced by chronic intermittent hypoxia in mice. | Int Immunopharmacol | 2024 | 38944951 | PubTator, text mining | PubMed |
| Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. | Prz Gastroenterol | 2024 | 38939059 | PubTator, text mining | PubMed |
| A multifunctional nanoplatform for chemotherapy and nanocatalytic synergistic cancer therapy achieved by amplified lipid peroxidation. | Acta Biomater | 2024 | 38936754 | PubTator, text mining | PubMed |
| The effect of TFAP2A/ANXA8 axis on ferroptosis of cervical squamous cell carcinoma (CESC) in vitro. | Cytotechnology | 2024 | 38933875 | PubTator, text mining | PubMed |
| Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways. | Mol Carcinog | 2024 | 38923019 | PubTator, text mining | PubMed |
| Unveiling the mechanism of photothermal therapy in acne man-agement: targeting sebaceous gland ferroptosis via umbilical cord mesenchymal stem cell membrane-encapsulated Au-Ag-PDA. | Front Bioeng Biotechnol | 2024 | 38915336 | PubTator, text mining | PubMed |
| Ferroptosis inhibitor improves outcome after early and delayed treatment in mild spinal cord injury. | Acta Neuropathol | 2024 | 38907771 | PubTator, text mining | PubMed |
| Overexpression of USP22 ameliorates LPS-induced endometrial stromal cells inflammation and modulates cells decidualization by inhibiting ferroptosis. | Reprod Biol | 2024 | 38896999 | PubTator, text mining | PubMed |
| Central role of Sigma-1 receptor in ochratoxin A-induced ferroptosis. | Arch Toxicol | 2024 | 38896176 | PubTator, text mining | PubMed |
| Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease. | Metabolism | 2024 | 38885833 | PubTator, text mining | PubMed |
| Notoginsenoside R1 (NGR1) regulates the AGE-RAGE signaling pathway by inhibiting RUNX2 expression to accelerate ferroptosis in breast cancer cells. | Aging (Albany NY) | 2024 | 38885076 | PubTator, text mining | PubMed |
| [Inhibition of Lung Squamous Cancer Target HMGCS1 Promotes Cellular Ferroptosis]. | Zhongguo Fei Ai Za Zhi | 2024 | 38880920 | PubTator, text mining | PubMed |
| Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy. | J Ethnopharmacol | 2024 | 38878839 | PubTator, text mining | PubMed |
| Ferroptosis as a promising targeted therapy for triple negative breast cancer. | Breast Cancer Res Treat | 2024 | 38874688 | PubTator, text mining | PubMed |
| ACLS4 could be a potential therapeutic target for severe acute pancreatitis. | Sci Rep | 2024 | 38862656 | PubTator, text mining | PubMed |
| Targeting ferroptosis regulators by natural products in colorectal cancer. | Front Pharmacol | 2024 | 38860170 | PubTator, text mining | PubMed |
| High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). | J Immunother Cancer | 2024 | 38857914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=57